Company

Dispatch Bio

Biotechnology Research 59 employees

Employees: 59
Contacts: 3
Emails: 3
Phones: 3

dispatchbio.com LinkedIn Crunchbase

Dispatch Bio Overview

Website: dispatchbio.com
Industry: Biotechnology Research
Employees: 59
Founded: 2022
Funding: 216.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Dispatch Bio

Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.

Dispatch Bio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

Dispatch Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jeff Marrazzo	Co-founder of Spark Therapeutics	Philadelphia, Pennsylvania, United States	Email Phone
Alison Blaus	Vice President, Head of Regulatory Affairs at Dispatch Bio	United States	Email Phone
Whitney Gladney	Translational Medicine Professional		View
Stanley Newman	Executive Director, Facilities, Real Estate & IT	Philadelphia, Pennsylvania, United States	Email Phone